EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders
In 2008 the European Molecular Genetics Quality Network (EMQN) for the first time offered a European-wide external quality assessment scheme for CAH (due to 21-OH deficiency).